Hot Features
Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Black Diamond Therapeutics Inc is a precision oncology medicine company. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its d... Black Diamond Therapeutics Inc is a precision oncology medicine company. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under pipeline are BDTX-189 and BDTX-1535. Mehr anzeigen
Announced encouraging initial Phase 2 data of BDTX-1535 in patients with recurrent EGFRm NSCLC with a broad spectrum of classical, non-classical, and C797S resistance mutations in September 2024...
CAMBRIDGE, Mass., Nov. 01, 2024 (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a clinical-stage oncology company developing MasterKey therapies that target families of...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.056 | 2.64150943396 | 2.12 | 2.67 | 1.91 | 3655032 | 2.28113301 | CS |
| 4 | -0.334 | -13.3067729084 | 2.51 | 2.67 | 1.91 | 1213534 | 2.25628279 | CS |
| 12 | -1.084 | -33.2515337423 | 3.26 | 3.44 | 1.91 | 739051 | 2.51366895 | CS |
| 26 | -3.524 | -61.8245614035 | 5.7 | 6.75 | 1.91 | 939371 | 3.94495293 | CS |
| 52 | -0.794 | -26.734006734 | 2.97 | 7.66 | 1.91 | 802251 | 4.37560895 | CS |
| 156 | -2.044 | -48.4360189573 | 4.22 | 7.66 | 1.18 | 771981 | 4.69148158 | CS |
| 260 | -30.824 | -93.4060606061 | 33 | 46.25 | 1.18 | 613142 | 8.34513851 | CS |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
